Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

35.36
Delayed Data
As of Dec 13
 -0.21 / -0.59%
Today’s Change
28.48
Today|||52-Week Range
46.81
+14.73%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close35.57
Today’s open35.51
Day’s range35.19 - 35.82
Volume517,914
Average volume (3 months)392,349
Market cap$1.5B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+40.06%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio62.0
Price/Sales10.05
Price/Book7.13

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...0.000.00%
ARRYArray Biopharma Inc+0.67+6.19%
LXRXLexicon Pharmaceutic...+0.45+4.50%
CBMCambrex Corp+0.20+0.40%
Data as of 4:02pm ET, 12/13/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts